drugset / Trial / NCT06536036
Evaluate the Effects of Food on the Pharmacokinetics of SIM0270
Phase 1
Completed
16 enrolled
Jiangsu Simcere Pharmaceutical Co., Ltd.
Nanjing Zaiming Pharmaceutical Co., Ltd. · collab
RandomizedCrossoverOpen-labelTreatment
Summary
This is a randomized, open label, single dose, two-period, crossover trial phase I study. The purpose of this study is to evaluate the food effect on the pharmacokinetics（PK） of SIM0270 after oral administration under fasted, standard meal, or high-fat diet conditions.
Timeline
- Start
- 2024-07-23
- Primary completion
- 2024-10-16
- Completion
- 2024-10-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SIM0270 | Unknown | 60 mg | Oral |
Indications
No indication recorded.